LOCALLY ADVANCED PANCREATIC DUCTAL ADENOCARCINOMA
Clinical trials for LOCALLY ADVANCED PANCREATIC DUCTAL ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED PANCREATIC DUCTAL ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED PANCREATIC DUCTAL ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug targets pancreatic cancer before surgery
Disease control Not yet recruitingThis early-stage trial tests a drug called samuraciclib in 15 people with localized pancreatic cancer that can be surgically removed. Participants will take the drug for about two weeks before their planned surgery. Researchers will check safety and look for changes in tumor cell…
Matched conditions: LOCALLY ADVANCED PANCREATIC DUCTAL ADENOCARCINOMA
Phase: PHASE1 • Sponsor: University of Washington • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Triple threat against pancreatic cancer: radiation, immunotherapy, and chemotherapy combined
Disease control Not yet recruitingThis phase 2 trial tests a new treatment approach for people with locally advanced pancreatic cancer that cannot be removed by surgery. Participants receive targeted radiation therapy followed by a combination of two immunotherapy drugs (ipilimumab N01 and sintilimab) plus standa…
Matched conditions: LOCALLY ADVANCED PANCREATIC DUCTAL ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Shandong Cancer Hospital and Institute • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC